ClinConnect ClinConnect Logo
Search / Trial NCT06342089

Prevalence And Severity Of Molar Incisor Hypomineralization Among A Group Of Children With Type I Diabetes Milletus.

Launched by CAIRO UNIVERSITY · Mar 26, 2024

Trial Information

Current as of May 03, 2025

Not yet recruiting

Keywords

Molar Incisor Hypomineralization (Mih) Type I Diabetes Milletus(tidm)

ClinConnect Summary

This clinical trial is looking at how common and severe a dental condition called molar incisor hypomineralization (MIH) is in children who have type I diabetes. MIH affects the way the teeth develop, making them weaker and more prone to cavities. The study will involve examining children aged 8 to 14 years who have type I diabetes and have all four of their first permanent molars. During the examination, the dentist will gently clean the teeth and use special tools to check for any issues without taking X-rays.

To be eligible for this trial, children must be between 8 and 14 years old, have type I diabetes, and have all four first permanent molars grown in. Children with braces, other types of enamel defects, or other health conditions that could affect their teeth will not be included. Participants can expect a thorough dental check-up where the severity of any MIH will be recorded, and the results will be monitored by the study team to ensure everything is done properly. This study aims to better understand the dental health challenges faced by children with diabetes and to identify any treatment needs they may have.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient aged 8 to 14 years and diagnosed with types I diabetes milletus.
  • Eruption of all 4 first permanent molars.
  • Acceptance to participate.
  • Exclusion Criteria:
  • Presence of orthodontic appliance.
  • Patient with any other type of enamel defect.
  • Patients with any other systemic conditions rather than types I diabetes milletus that may affect tooth development.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported